BD Diagnostics announced that the FDA has granted 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) Waiver for the BD Veritor System for Rapid Detection of Group A Strep. This is the first test Group A Strep test system with digital results that has received the CLIA Waiver.

The Group A Strep test incorporates Advanced Nano-particle and Adaptive Read technologies to obtain an accurate result while showing results on a hand held reader with an easy-to-read digital display. This digital immunoassay (DIA) for Rapid Detection of Group A Strep is a new option for Group A testing compared to the current visual read CLIA-waived assays.

RELATED: Infectious Disease Resource Center

Test results are delivered in about 8 minutes from specimen processing to results. Accurate determination of the etiology can aid healthcare providers choose more appropriate antibiotic treatments.


Continue Reading

The BD Veritor System for Rapid Detection of Group A Strep is cleared for use in hospitals, outpatient clinics, and other patient-care settings in conjunction with the BD Veritor System Reader.

For more information call (800) 638-8663 or visit BD.com